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Abstract
Objectives—Prior studies have reported that hospital-onset (HO)-sepsis is associated with higher 
mortality rates than community-onset (CO)-sepsis. Most studies, however, have used inconsistent 
case-finding methods and applied limited risk-adjustment for potential confounders. We used 
consistent sepsis criteria and detailed electronic clinical data to elucidate the epidemiology and 
mortality associated with HO-sepsis.
Design—Retrospective cohort study
Setting—136 U.S. hospitals in the Cerner HealthFacts dataset
Patients—Adults hospitalized in 2009–2015
Interventions—None
Measurements and Main Results—We identified sepsis using CDC Adult Sepsis Event 
criteria and estimated the risk of in-hospital death for HO-sepsis versus CO-sepsis using logistic 
regression models. In patients admitted without CO-sepsis, we estimated risk of death associated 
with HO-sepsis using Cox regression models with sepsis as a time-varying covariate. Models were 
adjusted for baseline characteristics and severity-of-illness. Among 2.2 million hospitalizations, 
there were 95,154 sepsis cases: 83,620 (87.9%) CO-sepsis and 11,534 (12.1%) HO-sepsis (0.5% 
of hospitalized cohort). Compared to CO-sepsis, HO-sepsis patients were younger (median 66 vs 
68 years) but had more comorbidities (median Elixhauser score 14 vs 11), higher Sequential Organ 
Failure Assessment scores (median 4 vs 3), higher ICU admission rates (61% vs 44%), longer 
hospital length-of-stay (median 19 vs 8 days), and higher in-hospital mortality (33% vs 17%) 
(p<0.001 for all comparisons). On multivariate analysis, HO-sepsis was associated with higher 
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mortality versus CO-sepsis (odds ratio 2.1, 95% CI 2.0–2.2) and patients admitted without sepsis 
(hazard ratio 3.0, 95% CI 2.9–3.2).
Conclusions—HO-sepsis complicated 1 in 200 hospitalizations and accounted for 1 in 8 sepsis 
cases, with 1 in 3 patients dying in-hospital. HO-sepsis preferentially afflicted ill patients but even 
after risk-adjustment they were twice as likely to die as CO-sepsis patients; in patients admitted 
without sepsis, HO-sepsis tripled the risk of death. HO-sepsis is an important target for 
surveillance, prevention, and quality improvement initiatives.
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INTRODUCTION
Sepsis is a leading cause of death in hospitalized patients.[1, 2] Local and national initiatives 
now seek to improve early sepsis recognition and treatment. To date, much of this effort has 
focused on patients presenting to the hospital with sepsis.[3–7] However, epidemiologic 
studies suggest that hospital-onset sepsis may account for 10–20% of sepsis cases and is 
associated with worse outcomes compared to community-onset sepsis.[8–10]
More attention is now being directed towards improving recognition and treatment of 
hospital-onset sepsis [11], but there remain important gaps in our knowledge. In particular, it 
is unclear to what degree the poor outcomes associated with hospital-onset sepsis are due to 
patient’s underlying comorbidities and severity-of-illness versus modifiable factors such as 
quality of care.[2] Prior studies provide limited insight into this question and the true 
epidemiology of hospital-onset sepsis since most have used administrative data to identify 
sepsis. Administrative data are unreliable for sepsis surveillance, however, because clinicians 
and hospitals differ widely in their diagnosis patterns as well as their completeness and 
specificity of coding for sepsis and organ dysfunction.[12–14] In addition, administrative 
analyses use present-on-admission codes to differentiate hospital versus community-onset-
sepsis but these are often inaccurate and variably used by hospitals.[15–17] Finally, 
administrative data do not allow for detailed risk-adjustment for patients’ severity-of-illness 
on admission and at the time of sepsis onset.
The U.S. Centers for Disease Control and Prevention (CDC) recently released the Adult 
Sepsis Event surveillance definition that uses objective clinical data to identify sepsis cases, 
thereby enhancing the consistency of surveillance across hospitals.[18, 19] Importantly, 
Adult Sepsis Events flags the day of sepsis onset using clinical criteria, allowing more 
precise differentiation between hospital-onset versus community-onset sepsis.[19]
In this study, we used CDC Adult Sepsis Event criteria and detailed electronic health record 
(EHR) data to elucidate the epidemiology of hospital-onset sepsis and its association with 
mortality in a large set of diverse hospitals.
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METHODS
Study Design, Data Source, and Population
This was a retrospective cohort study using the Cerner HealthFacts dataset, a de-identified 
database populated with clinical data from geographically diverse U.S. hospitals.[1, 20–23] 
The study cohort included adult patients (≥20 years old) admitted as inpatients from January 
2009 through September 2015 to 136 hospitals previously used in a national epidemiologic 
study of sepsis.[1] We included all hospitals that reported all data elements necessary to 
identify Adult Sepsis Events, including laboratory test results, medications, and blood 
culture orders. Hospitals did not necessarily report data in each year of the study period. 
Hospitalizations with missing discharge dispositions or those with International 
Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) rather than 
ICD-9-CM codes were excluded. This study was approved by the Institutional Review Board 
at Harvard Pilgrim Health Care Institute with a waiver of informed consent.
Identifying Hospital-Onset vs Community Onset Sepsis
Sepsis cases were identified using CDC’s Adult Sepsis Event criteria, which flag 
hospitalizations with clinical indicators of presumed serious infection and concurrent organ 
dysfunction.[18] This definition is optimized for objective retrospective surveillance using 
EHR data and has high concordance with Sepsis-3 criteria.[1, 19, 24] Presumed serious 
infection is defined as a blood culture order and administration of ≥4 consecutive days of 
new antibiotics starting within +/−2 days. Fewer than 4 antibiotic days are allowed if death, 
discharge to hospice, or discharge to another acute care hospital occurs before 4 days. Organ 
dysfunction is defined as the initiation of vasopressors or mechanical ventilation, lactate 
≥2.0 mmol/L, doubling in baseline creatinine or decrease in estimated glomerular filtration 
rate by ≥50%, doubling in total bilirubin to ≥2.0 mg/dL, or ≥50% decrease in platelet count 
to <100 cells/μL.
As per CDC criteria, sepsis was defined as hospital-onset if the blood culture, first antibiotic 
day, and organ dysfunction all occurred on hospital day 3 or later (with hospital day 1 being 
the day of admission).[18] Patients meeting any sepsis criteria before day 3 were defined as 
community-onset sepsis. Patients with community-onset sepsis who later developed 
hospital-onset sepsis were counted as community-onset sepsis cases, such that the two 
groups were mutually exclusive.
Statistical Analyses
Two sets of modeling analysis results are presented. The first model included patients 
admitted without community-onset sepsis. To estimate the risk of mortality associated with 
developing hospital-onset sepsis, we used a Cox regression model with sepsis as a time-
varying covariate. We adjusted for baseline characteristics, including demographics (age, 
sex, race) and comorbidities using the Agency for Healthcare Research and Quality (AHRQ) 
modified Elixhauser comorbidity index based on ICD-9-CM codes.[25] We also adjusted for 
some comorbidities not included in the Elixhauser index that might influence sepsis 
outcomes (leukemia [ICD-9-CM codes 204–208], stem cell transplant [V42.81 and V42.82], 
and solid organ transplant [V42.0–42.7, V42.83, V42.84, V42.89, V42.9]). We further 
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adjusted for year of admission, hospital characteristics (region, bed size, and teaching vs 
non-teaching), admission from a healthcare facility, and severity-of-illness at hospital 
presentation (using the worst values within +/−1 day of admission) through vital signs 
(temperature, systolic blood pressure, respiratory rate), Glasgow coma scale, vasopressor 
use, need for mechanical ventilation, care in the intensive-care-unit (ICU), and laboratory 
data (serum lactate, creatinine, bilirubin, liver function tests, platelet count, hematocrit, 
sodium, and anion gap). We also adjusted for positive blood cultures (excluding common 
skin contaminants) and for suspected infection on admission, defined by sampling of clinical 
cultures from any anatomic site and any antibiotic administration.
The second model included patients who had sepsis, either of community-onset or hospital-
onset. To evaluate the effect of hospital-onset versus community-onset sepsis on risk of 
mortality, we conducted a multivariate logistic regression analysis. We adjusted for similar 
covariates as described above except that when controlling for severity of illness, we used 
the worst physiologic parameters within +/−1 calendar day of sepsis onset (defined as the 
earliest day the index blood culture was drawn or antibiotic first administered within the 
window meeting Adult Sepsis Event criteria) for hospital-onset sepsis. In addition, we 
controlled for source of infection (pneumonia, urinary, intra-abdominal, skin/soft tissue 
infection, septicemia, central nervous system, obstetric/gynecologic, two or more, or none of 
these), identified through ICD-9-CM codes (Supplemental Table 1) and positive blood 
cultures at sepsis onset.[26]
Multiple imputation was used to account for missing data in severity-of-illness covariates 
(described further in the Supplemental Methods). In contrast to laboratory data, vital signs 
and Glasgow Coma scale are inconsistently reported by hospitals in Cerner HealthFacts but 
data availability was substantially higher in 2013–2013 vs 2009–2012. Therefore, we 
conducted a sensitivity analysis in the subset of patients admitted in 2013–2015. In the 
2013–2015 subset, we also conducted a sensitivity analysis replacing all physiologic 
parameters (laboratory data, vasopressors, mechanical ventilation, vital signs, Glasgow 
Coma Scale) with the Sequential Organ Failure Assessment (SOFA) score in order to create 
a more parsimonious model based on an established severity-of-illness score.[24, 27] Lastly, 
we conducted a sensitivity analysis limited to patients across the entire 2009–2015 study 
cohort with no missing covariates. All tests of significance used two-sided p-values at ≤0.05. 
Analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) and R version 
3.3.1 (r-project.org).
RESULTS
Patient Characteristics
The study cohort included 2,216,032 adult hospital encounters from 136 hospitals (Figure 
1). The highest geographic representation of hospitals was from the South (35%), and most 
were nonteaching facilities (60%) and had fewer than 200 beds (65%) (Supplemental Table 
2). Of the 2.2 million hospitalized patients, 95,154 had sepsis (4.3%), and 11,534 (12.1%) of 
these were hospital-onset (0.5% of the entire hospitalized cohort). Of the hospital-onset 
sepsis patients, 4,840 (42.0%) were in an ICU on the day of sepsis onset.
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Patient characteristics are shown in Table 1. Compared to community-onset sepsis, hospital-
onset sepsis patients were slightly younger (median age 66 vs 68) but had more 
comorbidities (median AHRQ Elixhauser score 14 vs 11) including heart failure (26.2% vs 
21.8%), renal disease (23.6% vs 19.7%), and cancer (17.7% vs 11.2%) (p<0.001 for all 
comparisons). Hospital-onset sepsis patients had higher rates of intra-abdominal infections 
(20.6% vs 15.6%) but slightly lower rates of pneumonia (23.9% vs 25.6%), urinary tract 
infections (24.1% vs 27.3%), and skin/soft tissue infection (6.9% vs 7.8%) (Figure 2A). 
Hospital-onset sepsis patients also had higher rates of positive blood cultures (18.8% vs 
15.5%). The distribution of the most frequent bloodstream pathogens differed between the 
two groups; Escherichia, Staphylococcus aureus, and Streptococcus species were the 3 most 
common pathogens in community-onset sepsis, while Staphylococcus aureus, Enterococcus, 
and Candida species were the most common in hospital-onset sepsis (Table 2). Hospital-
onset sepsis patients had higher SOFA scores at sepsis onset (median 4 vs 3, p<0.001) and 
met Adult Sepsis Event organ dysfunction criteria more often from vasopressors (48.0% vs 
30.5%) and mechanical ventilation (25.4% vs 21.8%) as opposed to elevated lactate (31.2% 
vs 41.5%) and doubling in creatinine (26.2% vs 40.1%) (Figure 2B). Among hospital-onset 
sepsis patients with cancer diagnoses (n=2,040), 550 (27.0%) had leukopenia (as defined by 
white blood cell count <2.0 × 109 cells/L) on the day of sepsis onset, compared to 1,084 of 
9,494 (11.4%) hospital-onset sepsis patients without cancer (p<0.001).
Hospitalized patients without sepsis (n=2,120,878) tended to be younger than either 
community or hospital-onset sepsis (median age 59), with fewer comorbidities (median 
Elixhauser score 0) and rarely had diagnosis codes for infectious syndromes or laboratory-
confirmed bacteremia (Table 1).
Risk of Death from Acquiring Hospital-Onset Sepsis
Compared to hospitalized patients who never developed sepsis, those who acquired hospital-
onset sepsis were more frequently admitted to the ICU (60.7% vs 8.7%), had longer hospital 
lengths-of-stay (median 19 vs 4 days) and ICU length-of-stays (median 6 vs 3 days), and 
died more often (33.4% vs 1.6%) (p<0.001 for all). Without adjustment for baseline 
characteristics and severity-of-illness, the hazard ratio for death associated with hospital-
onset sepsis was 5.1 (95% 4.9–5.3). Adjusting for confounders diminished but did not 
eliminate the increased risk of death associated with hospital-onset sepsis (hazard ratio 3.0, 
95% CI 2.9–3.2) (full model shown in Supplemental Table 3).
The quantity of missing data in 2013–2015 vs the entire 2009–2015 cohort is shown in 
Supplemental Table 4. A sensitivity analysis restricting the cohort to patients admitted from 
2013–2015 (with more complete vital sign and GCS data) demonstrated similar results, as 
did sensitivity analyses using the SOFA score for severity-of-illness adjustment and 
restricting the cohort to patients without any missing covariates (Supplemental Table 5).
Risk of Death in Hospital-Onset vs Community-Onset Sepsis
Compared with community-onset sepsis, patients with hospital-onset sepsis had longer 
hospital lengths-of-stay (median 19 vs 8 days), were admitted to the ICU more often (60.7% 
vs 44.1%), had longer ICU lengths-of-stay (median 6 vs 4 days), and had higher in-hospital 
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mortality rates (33.4% vs 16.8%, unadjusted odds ratio 2.5, 95% CI 2.4–2.6). On 
multivariate analysis, hospital-onset sepsis remained significantly associated with higher risk 
of in-hospital death compared to community-onset sepsis (adjusted odds ratio 2.1, 95% CI 
2.0–2.2) (full model shown in Supplemental Table 3). Sensitivity analyses limited to 
hospitalizations in 2013–2015, using the SOFA score for severity-of-illness adjustment, and 
restricting the cohort to patients without any missing covariates yielded similar results 
(Supplemental Table 5).
DISCUSSION
Using clinical data from a large cohort of U.S. hospitals, we found that hospital-onset sepsis 
complicated 1 in 200 hospitalizations and increased the hazard of death 3-fold in patients 
initially admitted without sepsis after adjusting for baseline characteristics and severity-of-
illness on admission. Hospital-onset sepsis accounted for 1 in 8 sepsis cases; these patients 
had more comorbidities and more organ dysfunction than those with community-onset 
sepsis. After adjusting for confounders, hospital-onset sepsis was still associated with a 2-
fold higher odds of death compared to community-onset sepsis.
Our estimates of the burden of hospital-onset sepsis fall within the range reported using 
administrative data.[8–10] Using present-on-admission flags and an “implicit” sepsis 
definition based on infection and organ dysfunction codes, Page et al. found that 11% of 
sepsis cases in academic hospitals in the University HealthSystems Consortium were 
hospital-acquired, with mortality rates of 19% vs 9% for community-onset sepsis.[8] 
Another analysis in the Premier Healthcare Database using explicit sepsis codes reported 
hospital-onset sepsis accounted for 13% of all sepsis cases, with mortality rates of 31% vs 
13% for present-on-admission sepsis.[10] Similar findings were reported in a 6-hospital 
system in Texas using explicit sepsis codes.[9]
Our analysis expands on these prior studies by using CDC Adult Sepsis Event criteria, 
which are more sensitive than explicit sepsis codes, more specific than implicit sepsis codes, 
and allow for more consistency in sepsis detection between hospitals.[1] Adult Sepsis Events 
are also better suited to identifying the timing of sepsis onset since present-on admission 
codes are variably applied by hospitals and often inaccurate.[15–17] This reduces the risk of 
misclassification and allows for better adjustment for time-dependent bias. Our analysis also 
incorporated detailed physiologic and laboratory data to provide more robust risk-adjustment 
than possible using administrative data alone.
There are relatively few other data on the additional risk of death conferred by developing 
sepsis in the hospital. One prospective study found that among patients initially admitted to 
the ICU with a non-infectious diagnosis, ICU-onset infections carried an attributable 
mortality fraction of 21%.[28] Two single-center cohorts estimated an adjusted hazard ratio 
of 1.5 and adjusted odds ratio of 1.7, respectively, for mortality associated with nosocomial 
infection after controlling for confounders.[29, 30] Our study provides sepsis-specific 
estimates and is more generalizable since it draws from a larger cohort of hospitals and also 
includes non-ICU patients. The latter is particularly important since we found that more than 
half of hospital-onset sepsis events occurred outside of the ICU.
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Our findings also shed light on specific differences in the types of patients that develop 
hospital-onset versus community-onset sepsis. For example, cancer was more common in 
hospital-onset sepsis patients. Cancer patients receiving chemotherapy agents that induce 
neutropenia or other immunosuppressed states may be predisposed to hospital-onset sepsis, 
and sepsis is associated with very poor outcomes in this population.[31] This is supported by 
the high rate of leukopenia (27%) when hospital-onset sepsis developed in cancer diagnoses 
in our dataset. Patterns of infections were also different, with more intra-abdominal 
infections in hospital-onset sepsis. This is concordant with reports suggesting that surgical 
patients have higher rates of hospital-onset sepsis.[8] The higher severity-of-illness in 
hospital-onset sepsis patients was reflected by higher SOFA scores and more frequent need 
for vasopressors and mechanical ventilation at sepsis onset, whereas community-onset sepsis 
more frequently had elevated lactate levels and acute kidney injury.
The persistent two-fold higher odds of death with hospital-onset versus community-onset 
sepsis even after risk-adjustment begs the question of whether this is due to residual 
confounding or potentially modifiable care factors. One potential explanation is the higher 
incidence of antibiotic-resistant strains in hospital-acquired infections, which may contribute 
to inappropriate empiric antibiotics and higher mortality in hospital-onset sepsis.[32, 33] In 
addition, inpatient clinical teams may be slower to recognize and manage hospital-onset 
sepsis compared to clinicians in the emergency department, where a large amount of 
attention has been paid to implementing sepsis recognition and treatment bundles.[3–7, 34] 
Underscoring these differences, prior studies have found that serum lactates are less likely to 
be drawn in hospital-onset sepsis, while a recent analysis found lower compliance with the 
Centers for Medicare and Medicaid Services “SEP-1” bundle in hospital-onset vs 
community-onset sepsis cases.[35–37] This may point to an opportunity to reduce sepsis 
morbidity and mortality by developing systems to improve recognition and management of 
hospital-onset sepsis.[11]
Our study has important limitations. First, our findings may not necessarily generalize to all 
hospitals, particularly to large academic hospitals as these were underrepresented in our 
sample. Second, our definition of community-onset sepsis does not distinguish infections 
acquired in prior healthcare settings from infections acquired in the community. However, 
we included admission from healthcare facilities as a covariate in our models. Third, we 
defined community-onset and hospital-onset sepsis as mutually exclusive groups, but some 
patients with community-onset sepsis also develop hospital-onset sepsis. Our results may 
therefore underestimate the incidence of hospital-onset sepsis. Fourth, we relied on 
administrative data to identify the likely source of infection, which may have limited 
accuracy and variable performance across hospitals. Fifth, data missingness was high in our 
dataset for vital signs and Glasgow Coma Scale. However, results of our regression analyses 
were consistent in sensitivity analyses limiting the cohort to the later years when these data 
were more populated, and in patients with non-missing data. Sixth, the granularity of 
severity-of-illness variables was limited to calendar days, and it is possible that our analyses 
might have inadvertently adjusted for abnormal physiology on the causal pathway from 
sepsis onset to death. More precise severity-of-illness adjustment at the moment of sepsis 
onset or immediately prior might yield more reliable estimates of the mortality risk with 
hospital-onset versus community-onset sepsis. However, identifying the exact sepsis “time 
Rhee et al. Page 7
Crit Care Med. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
zero” is a major challenge even on detailed medical reviews, particularly for hospital-onset 
sepsis.[38] Furthermore, adjusting for the worst physiologic parameters around the day of 
sepsis onset rather than the preceding day allowed for parity in our comparison of hospital-
onset vs community-onset sepsis since patients in the latter group presented to the hospital 
with sepsis. Lastly, as with all observational studies, our findings are at risk for residual 
confounding. Potential important factors we were unable to adjust for due to dataset 
limitations included vasopressor doses, PaO2:FiO2 ratios, patient insurance status, admitting 
service for hospitalized patients, Medicare Severity Diagnosis Related Groups, and 
antibiotic-resistance patterns. There may also be other subtle markers of frailty as well as 
concurrent acute illnesses in hospitalized patients that develop sepsis that cannot be easily 
measured using EHR and administrative data. This is an important topic for future research.
In conclusion, in this large U.S. cohort we found that hospital-onset sepsis complicated 1 in 
200 hospital admissions, accounted for 1 in 8 sepsis cases, and preferentially afflicted ill 
patients. Even after adjusting for severity-of-illness, hospital-onset sepsis patients were 
twice as likely to die as community-onset sepsis patients; in patients admitted without 
sepsis, hospital-onset sepsis tripled the risk of death. These findings underscore the 
importance of targeting hospital-onset sepsis with surveillance, prevention, and quality 
improvement efforts.
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Figure 1. 
Study cohort derivation from Cerner HealthFacts dataset
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Figure 2. Comparison of major clinical characteristics in patients with hospital-onset sepsis, 
community-onset sepsis, and no sepsis.
A, Infectious diagnoses and syndromes in patients with hospital-onset vs community-onset 
sepsis vs no sepsis. All categories were identified by ICD-9-CM discharge diagnosis codes, 
except for positive blood cultures (obtained by microbiology data). B, Dysfunctional organs 
(by Centers for Disease Control and Prevention Adult Sepsis Event Criteria) at sepsis onset.
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Table 1.
Characteristics of Hospitalized Patients with Hospital-Onset Sepsis, Community-Onset Sepsis, and No Sepsis
Characteristics No Sepsis (N=2,120,878) Community-Onset Sepsis 
(N=83,620)
Hospital-Onset Sepsis 
(N=11,534)
Median Age (IQR) 59 (42–74) 68 (55–80) 66 (55–77)
Sex
 Male (or Unknowna) 868171 (40.9%) 40,093 (48.0%) 6,186 (53.6%)
 Female 1,252,707 (59.1%) 43,519 (52.0%) 5,348 (46.4%)
Race
 White 1,524,588 (71.9%) 61,744 (73.8%) 7,826 (67.9%)
 Black 401,836 (18.9%) 15,408 (18.4%) 2,766 (24.0%)
 Other (or Unknown)a 194,4454 (9.2%) 6,468 (7.7%) 942 (8.2%)
Select Comorbiditiesb
 Cancer 122,410 (5.8%) 9,365 (11.2%) 2,040 (17.7%)
 Chronic Lung Disease 332,744 (15.7%) 19,843 (23.7%) 2,439 (21.2%)
 Congestive Heart Failure 217,932 (10.3%) 18,260 (21.8%) 3,025 (26.2%)
 Diabetes 465,303 (21.9%) 24,789 (29.6%) 3,205 (27.8%)
 Liver Disease 54,828 (2.6%) 4,813 (5.8%) 851 (7.4%)
 Neurologic Disease 181,685 (8.6%) 14,866 (17.8%) 1,728 (15.0%)
 Peripheral Vascular Disease 46,832 (2.2%) 6,663 (8.0%) 1,428 (12.4%)
 Renal Disease 222,006 (10.5%) 16,482 (19.7%) 2,720 (23.6%)
AHRQ Elixhauser Scorec 0 (-1–8) 11 (3–20) 14 (5–24)
Admitted from Healthcare Facilityd 138,192 (6.5%) 9,571 (11.5%) 1,523 (13.2%)
ICU on Day of Sepsis Onset N/A 32,692 (39.1%) 4,840 (42.0%)
SOFA Score on Day of Sepsis Onset N/A 3 (2–5) 4 (2–7)
Positive Blood Cultures 25,098 (1.2%) 12,951 (15.5%) 2,163 (18.8%)
Hospital LOS 4 (3–6) 8 (5–13) 19 (12–30)
Admitted to ICU 184,671 (8.7%) 36,868 (44.1%) 7,006 (60.7%)
ICU LOS 3 (2–4) 4 (3–7) 6 (3–11)
Death 32,937 (1.6%) 14,025 (16.8%) 3,851 (33.4%)
Abbreviations: AHRQ = Agency for Healthcare Research and Quality, ICU = intensive care unit, SOFA = Sequential Organ Failure Assessment, 
LOS = length-of-stay.
aSex was missing in 499 cases (0.02%) and race was missing in 40,699 cases (1.8%).
b
The cancer comorbidity includes the Elixhauser categories of solid tumor without metastases, metastatic tumor, and lymphoma. It also includes 
codes for leukemia. Diabetes includes diabetes with and without complications.
c
The AHRQ Elixhauser score is weighted and allows for negative points for comorbidities with an inverse association with mortality.
d
Healthcare facilities include acute care hospitals, non-acute care facilities, hospice, and ambulatory surgery centers.
p-values were <0.001 for all comparisons between hospital-onset and community-onset sepsis.
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Table 2.
Top 10 Most Frequent Blood Culture Pathogens in Patients with Community-Onset vs Hospital-Onset Sepsis
Rank Community-Onset Sepsis (n=12951) Hospital-Onset Sepsis (n=2,163)
1 Escherichia – 2,876 (22.2%) Staphylococcus aureus - 514 (23.8%)
2 Staphylococcus aureus - 2,592 (20.0%) Enterococcus - 243 (11.2%)
3 Streptococcus – 2,283 (17.6%) Candida - 240 (11.1%)
4 Klebsiella – 1,090 (8.4%) Escherichia - 236 (10.9%)
5 Enterococcus – 806 (6.2%) Klebsiella - 220 (10.2%)
6 Candida - 566 (4.4%) Streptococcus - 160 (7.4%)
7 Proteus - 476 (3.7%) Pseudomonas – 133 (6.1%)
8 Pseudomonas – 454 (3.6%) Enterobacter – 73 (3.4%)
9 Enterobacter – 290 (2.2%) Acinetobacter – 43 (2.0%)
10 Serratia – 139 (1.1%) Bacteroides – 36 (1.7%)
For each hospitalization, only the first positive blood culture was counted.
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